James Huang - 30 Jun 2025 SCHEDULE 13G/A Report for CASI Pharmaceuticals, Inc. Ordinary Shares (CASI)

Filing Manager
James Huang
Reporting Manager
James Huang
Security
CASI Pharmaceuticals, Inc. Ordinary Shares
Symbol
CASI
Shares outstanding
15,663,558 shares
Disclosed Ownership
2,161,571 shares
Ownership
14%
Form type
SCHEDULE 13G/A
Filing time
23 Jul 2025, 09:39:43 UTC
Date of event
30 Jun 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Panacea Venture Healthcare Fund II, L.P. 13% 2,050,000 0 2,050,000 By: Panacea Venture Healthcare Fund II GP Company, Ltd., its general partner, By: Panacea Innovation Limited, its sole owner, /s/ James Huang James Huang, Founding Managing Partner
Panacea Venture Healthcare Fund II GP Company, Ltd. 13% 2,050,000 0 2,050,000 By: Panacea Innovation Limited, its sole owner, /s/ James Huang James Huang, Founding Managing Partner
Panacea Innovation Limited 13% 2,050,000 0 2,050,000 /s/ James Huang James Huang, Founding Managing Partner
James Huang 14% 2,161,571 111,571 2,050,000 /s/ James Huang James Huang